The University of Chicago Header Logo

Connection

Richard Larson to Phosphorylation

Back to Details
This is a "connection" page, showing publications Richard Larson has written about Phosphorylation.
Richard Larson
Connection Strength
0.027
Phosphorylation
  1. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study. Lancet Oncol. 2017 08; 18(8):1061-1075.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.